Rep. Dunn Introduces the PSA Screening for HIM Act to Eliminate Copays for Prostate Cancer Tests
This bill is currently sitting in the House Committee on Energy and Commerce. No action has been taken on this proposal since February 2025, which means it has been stalled for over one year. The committee must review the bill before it can move forward, but most bills like this never receive a vote.
The bill has support from both parties and addresses a clear health disparity, but it must still pass through committees and compete with other legislative priorities.
This bill’s path across every version that has carried it.
Reintroduced
Reintroduced from H.R. 1826 (118th), which died when its Congress ended.
H.R. 1826 (118th) →Scores run from -100 (strongly harmful) to +100 (strongly beneficial) for each group, combining impact, certainty, scope, and duration ratings of 1-5. How impact scoring works
Small businesses offering group health plans would be required to include no-cost prostate cancer screenings for eligible employees. While this could marginally increase premiums, the cost is likely modest since PSA blood tests are inexpensive. On the positive side, early detection could reduce expensive late-stage treatment costs that drive up group plan premiums over time.
“The cost of treating metastatic prostate cancer in the United States health care system is hundreds of millions of dollars more annually than the cost of treating localized, early-stage cancer.”
Referred to the House Committee on Energy and Commerce.
Introduced in House
The bill was officially filed and given a number. It now enters the legislative queue.
The PSA Screening for HIM Act (H.R. 1300/S. 297) is a bipartisan bill aimed at improving access by waiving cost-sharing requirements like deductibles and copays for high-risk men. This comes as data shows a reversal in incidence trends, with advanced-stage diagnoses increasing by up to 4.8% annually.
Advocates are pushing for the PSA Screening for HIM Act to remove financial barriers for high-risk individuals. The bill would require private insurance to cover screenings without out-of-pocket costs, addressing disparities where Black men face mortality rates over twice as high as white men.
Senators Cory Booker and John Boozman introduced the PSA Screening for HIM Act to waive cost-sharing for high-risk men. The legislation aims to reduce health disparities, noting that prostate cancer detected in Stage 1 is almost 100% survivable compared to below 30% if caught in later stages.
No votes or related bills recorded for this bill yet.
Document Type
Congressional Bill
Official Title
PSA Screening for HIM Act
Analysis generated by AI. Always verify with official sources.